|Day Low/High||37.47 / 37.73|
|52 Wk Low/High||35.73 / 45.38|
The earnings growth picture may actually look decent. But there's a caveat to that caveat.
Right now, AbbVie is the best way to capitalize on the moment and on the future.
Cramer says with these unrelenting trade pressures, investors shouldn't do anything outrageous, anything fancy. They should hold tight and wait for when China isn't so in the balance.
We like AbbVie down here because we think the Allergan deal puts AbbVie's back in control of its own destiny.
Wise investors should stick with those equities and stay away from high-yielders with no protection, like the MLPs.
A volatile week ends with heightened expectations for at least one more rate cut from the Fed.
BP shares ticked higher in London Friday, outpacing the broader FTSE 100 benchmark, after the company said long-serving CEO Bob Dudley will step down next year to make way for incoming boss Bernard Looney.
Jim Cramer says earnings worries are weighing on stocks, but investors should seek out companies whose reports are not as bad as everyone feared they would be.
Jim Cramer weighs in on Raytheon, United Technologies, Yeti, Bristol-Myers Squibb, Mosaic, Square, JBG Smith Properties, Encana, BP, Waste Management.
With the market expected to continue Tuesday's weak ISM PMI-driven woes, we are in position to do some buying at newly discounted prices.
How much has central bankers' environment been impacted externally? We will see.
Could big oil be impacted if BP's CEO is planning to retire as reports suggest?
Here's what's driving markets Monday.
Curious about what's driving markets?
Three things you must know about Boeing, BP, and Forever 21.
U.S. stock futures rise after a U.S. Treasury official says the Trump administration doesn't have plans to stop Chinese companies from listing on U.S. exchanges; Boeing reportedly omitted key safeguards on the 737 MAX flight-control system; BP's CEO is reportedly preparing to step down; 'Abominable' wins the weekend box office.
Markets buffeted by impeachment turmoil and shift away from high-multiple growth names.
TWLO is tempting to buy right now into the teeth of the decline.
Markets traded mostly flat this week in spite of Saudi oil attacks, and a Fed rate cut, only turning sour on Friday on signs of renewed U.S. trade tensions with China.
Tomorrow's interest-rate decision is still viewed as a toss-up.
We want to nibble on Novartis, which is barely reacting to company-specific positive news.
Stocks finished down, ending the Dow's eight-day winning streak, after oil prices surge the most in more than two decades following an attack on two key Saudi Arabian oil facilities.
Chevron and Exxon Mobil appear more attractive than this stock right now, and the oil sector as a whole should be watched for at least the next couple days.
U.S. oil and energy stocks rise across the board Monday, and providing some upside support for the Dow Jones Industrial Average, after a series of weekend drone attacks on two key Saudi Arabian facilities lifted crude prices to their biggest single-day gain in more than two decades.
Jim discusses Monday's moves in the energy market, our decision to trim BP and Schlumberger into today's strength, some of our non-energy stocks that stand to benefit and more!
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.